Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Tropical Gastroenterology & Nutrition Group (TROPGAN) is a leading Zambian non-profit research and clinical organization dedicated to improving digestive, liver, and nutritional health in tropical regions. Established in 1999 and based at the University Teaching Hospital in Lusaka, TROPGAN conducts high-impact clinical trials, translational research, and observational studies focusing on conditions such as severe acute malnutrition, gastrointestinal cancers, and environmental enteric dysfunction. The organization collaborates extensively with international partners like Queen Mary University of London and the Bill & Melinda Gates Foundation to develop innovative therapies and diagnostic tools. TROPGAN also operates a specialized biobank and provides expert clinical care for patients with complex gastrointestinal and nutritional disorders in sub-Saharan Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TROPGAN.